WeLeader Biomedical Co. vs Abbott Laboratories: Fair Value & Quality
Both stocks run through our valuation models. Here is how WeLeader Biomedical Co. (7713) and Abbott Laboratories (ABT) compare, as of Sep 25, 2026.
Head-to-head numbers
Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.
betterweakerfor reference, not scored
WeLeader Biomedical Co. leads: 12 to 2 metric wins.
n/a = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | WeLeader Biomedical Co.Price TWD 73.80 | Abbott LaboratoriesPrice $103 |
|---|---|---|
| DCF Models | ▼-29%below the priceTWD 52.23 | ▼-28%below the price$74.80 |
| Earnings-Based | ▼-60%below the priceTWD 29.63 | ▼-72%below the price$29.42 |
| Dividend Discount | ▼-50%below the priceTWD 37.03 | ▼-62%below the price$39.73 |
| Multiples | ▲+15%above the priceTWD 85.03 | ▼-32%below the price$70.72 |
| Asset-Based | ▼-75%below the priceTWD 18.56 | ▼-81%below the price$20.05 |
| Growth DCF | ▼-50%below the priceTWD 36.89 | ▼-34%below the price$68.58 |
| Economic Profit | ▼-58%below the priceTWD 31.33 | ▼-64%below the price$37.49 |
| Growth Earnings | ▲+19%above the priceTWD 87.94 | ▼-32%below the price$70.25 |
| Minimum | ▼-75%below the priceTWD 18.56 | ▼-81%below the price$20.05 |
| Maximum | ▲+19%above the priceTWD 87.94 | ▼-28%below the price$74.80 |
| Median | ▼-50%below the priceTWD 36.96 | ▼-48%below the price$54.15 |
| Geometric mean | ▼-43%below the priceTWD 41.73 | ▼-55%below the price$46.64 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
WeLeader Biomedical Co.: 18 of 26 models see the stock below the current price.
Abbott Laboratories: 26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
WeLeader Biomedical Co. · Health Care
Abbott Laboratories · Health Care
Bottom line
As of Sep 25, 2026, Fair Value Calculator sees WeLeader Biomedical Co. as the less overvalued of the two: WeLeader Biomedical Co. trades at TWD 73.80 versus a fair value of TWD 55.88 (-24%), while Abbott Laboratories trades at $103 versus $74.79 (-28%).
Abbott Laboratories has the higher quality score (66/100).
Open WeLeader Biomedical Co. live analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to WeLeader Biomedical Co.
Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor ManufacturingSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.